{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 470474772
| IUPAC_name = ''N''-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide
| image = Sultopride.svg
| width = 240

<!--Clinical data-->
| tradename = Barnetil, Barnotil, Topral
| Drugs.com = {{drugs.com|international|sultopride}}
| pregnancy_category =  
| legal_status = Rx-only
| routes_of_administration = [[oral administration|Oral]], [[Intramuscular|IM]]

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life = 3–5 hours
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 53583-79-2
| ATC_prefix = N05
| ATC_suffix = AL02
| PubChem = 5357
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5164
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = AA0G3TW31W
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08549
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 277945

<!--Chemical data-->
| C=17 | H=26 | N=2 | O=4 | S=1 
| molecular_weight = 354.46 g/mol
| smiles = O=S(=O)(c1cc(c(OC)cc1)C(=O)NCC2N(CC)CCC2)CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H26N2O4S/c1-4-19-10-6-7-13(19)12-18-17(20)15-11-14(24(21,22)5-2)8-9-16(15)23-3/h8-9,11,13H,4-7,10,12H2,1-3H3,(H,18,20)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UNRHXEPDKXPRTM-UHFFFAOYSA-N
}}

'''Sultopride''' (trade names '''Barnetil''', '''Barnotil''', '''Topral''') is an [[atypical antipsychotic]] of the [[benzamide]] [[chemical class]] used in [[Europe]], [[Japan]], and [[Hong Kong]] for the treatment of [[schizophrenia]].<ref name="isbn3-527-31058-4">{{cite book |author1=José Miguel Vela |author2=Helmut Buschmann |author3=Jörg Holenz |author4=Antonio Párraga |author5=Antoni Torrens | title = Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application | publisher = Wiley-VCH | location = Weinheim | year = 2007 | isbn = 3-527-31058-4 | url = https://books.google.com/books?id=yXD4QA-Y_Z0C&lpg=PA537}}</ref><ref name="isbn3-88763-075-0">{{cite book | author = Swiss Pharmaceutical Society | title = Index Nominum 2000: International Drug Directory (Book with CD-ROM) | publisher = Medpharm Scientific Publishers | location = Boca Raton | year = 2000| isbn = 3-88763-075-0 | url = https://books.google.com/books?id=5GpcTQD_L2oC&lpg=PA1624&dq=sultopride&pg=PA983}}</ref><ref name="isbn3-7692-2114-1">{{cite book| title = European Drug Index, 4th Edition | publisher = CRC Press | location = Boca Raton | year = 1998 | isbn = 3-7692-2114-1| url = https://books.google.com/books?id=HiSdvzs2pPAC&lpg=PA136}}</ref> It was launched by [[Sanofi-Aventis]] in 1976.<ref name="isbn3-527-31058-4" /> Sultopride acts as a [[binding selectivity|selective]] [[D2 receptor|D<sub>2</sub>]] and [[D3 receptor|D<sub>3</sub> receptor]] [[receptor antagonist|antagonist]].<ref name="pmid16135699">{{cite journal  | title = Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 315 | issue = 3 | pages = 1278–87 | year = 2005| pmid = 16135699 | doi = 10.1124/jpet.105.092155  | last1 = Burstein  | first1 = E. S.  | last2 = Ma  | first2 = J  | last3 = Wong  | first3 = S  | last4 = Gao  | first4 = Y  | last5 = Pham  | first5 = E  | last6 = Knapp  | first6 = AE  | last7 = Nash  | first7 = NR  | last8 = Olsson  | first8 = R  | last9 = Davis  | first9 = RE  }}</ref> It has also been shown to have clinically relevant [[affinity (pharmacology)|affinity]] for the [[GHB receptor]] as well, a property it shares in common with [[amisulpride]] and [[sulpiride]].<ref>{{cite journal |vauthors=Maitre M, Ratomponirina C, Gobaille S, Hodé Y, Hechler V |title=Displacement of [3H] gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics |journal=Eur J Pharmacol. |volume=256 |issue=2 |pages=211–4 |year=1994 |pmid=7914168 |doi=10.1016/0014-2999(94)90248-8 }}</ref>

==References==
{{Reflist}}

{{Antipsychotics}}
{{Dopaminergics}}
{{GHBergics}}

[[Category:Atypical antipsychotics]]
[[Category:Benzamides]]
[[Category:GHB receptor ligands]]
[[Category:Phenol ethers]]
[[Category:Pyrrolidines]]
[[Category:Sulfones]]


{{nervous-system-drug-stub}}